All In Biotech

Drug Trial Radar · NCT00825500

Staccato Loxapine in Migraine (Out Patient)

A Multi-center, Randomized, Double-Blind, Placebo-Controlled, Single Dose Efficacy and Safety Study of Staccato® Loxapine for Inhalation in Outpatients With Migraine Headache

Last checked: Nov 20, 2026Latest source record: Apr 24, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 366 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

366

Actual

Start

Jan 2009

Primary completion

Aug 2009

Study completion Aug 2009

Sponsor

Lead sponsor
Alexza Pharmaceuticals, Inc.Not stated
Sponsor type
Not stated
First posted
Jan 21, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Assess the safety and efficacy of Staccato Loxapine in patients with moderate to severe migraine headache with or without aura in an outpatient setting.

Conditions

  • Migraine Headache

Interventions

  • Inhaled PlaceboDrug

    Inhaled Staccato placebo (0 mg)

  • Inhaled Loxapine 1.25 mgDrug

    Inhaled Staccato Loxapine 1.25 mg, single dose

  • Inhaled Loxapine 2.5 mgDrug

    Inhaled Staccato Loxapine 1.25 mg, single dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pain-Relief at 2 Hours Post-treatmentTime frame: 2 hours

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Roger K. Cady

    Springfield, Missouri

  • Elkind Headache Center

    Mount Vernon, New York

  • CNS Research, Inc.

    East Providence, Rhode Island

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.